News and features

Scientists have unveiled the first and largest encyclopaedia of protein alterations in soft tissue sarcomas – opening the door to a new era of understanding and treatment for this group of rare cancers.

Olympic gold medallist Greg Rutherford MBE and Paralympic gold medallist Erin Kennedy MBE launch an inspirational run for the ICR across 100 miles of British coastline – which will see ‘FINISH CANCER’ imprinted 167,000 times in the sand.

Professor Nicholas Turner, Professor of Molecular Oncology at The Institute of Cancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, where he is also Head of the Ralph Lauren Centre for Breast Cancer Research, has received the Translational Research Award by the European Society for Medical Oncology (ESMO).

Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future.

'We Dance for Life', a creative film that celebrates scientists from The Institute of Cancer Research, London, and The London Cancer Hub, has won the Best Dance Experimental award at the Experimental, Dance & Music Film Festival in the USA and Canada.

Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to the IMPORT HIGH trial.

An international study led by ICR scientists has accurately categorised tumour and immune cells of non-human animal species by applying an artificial intelligence (AI) algorithm that was trained on human lung cancer samples.

Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential.

A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.

Researchers have revealed, at high-resolution, the structure of a human protein complex named SIN3B, which is a ‘nanomachine’ involved in regulating cell division – a fundamental process for life which, if it becomes uncontrolled, can lead to cancer.

Pancreatic cancer cells can change their ‘diet’ to keep growing, by switching from the sugar glucose to a back-up fuel called uridine, new research reveals.